Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00206622Phase 4Completed
Phase 4, randomised, double-blind trial of estradiol topical in hot flashes (3 arms), sponsored by Bayer. Primary endpoints: Frequency of moderate to severe hot flushes and Severity of moderate to severe hot flushes. Started Dec 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00206622.